-+ 0.00%
-+ 0.00%
-+ 0.00%

HCW Biologics signed an exclusive distribution agreement with Akron Biotech to commercialize HCW11-006 as a reagent to support the production of highly functional human CAR-T cells.

智通財經·09/08/2026 12:57:05
語音播報
HCW Biologics signed an exclusive distribution agreement with Akron Biotech to commercialize HCW11-006 as a reagent to support the production of highly functional human CAR-T cells.